β-Catenin expression in primary and metastatic colorectal carcinoma

Thomas J. Hugh, Stephanie A. Dillon, Gerry O'Dowd, Brian Getty, Massimo Pignatelli, Graeme J. Poston, Anne R. Kinsella

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

β-catenin plays a fundamental role in the regulation of the E-cadherin- catenin cell adhesion complex. It also functions in growth signalling events, independently of the cadherin-catenin complex, and these signalling pathways are disturbed in colorectal cancer. Mutations in either the APC or β- catenin genes in colorectal cancer cells result in up-regulation of protein expression and subsequent cytoplasmic and nuclear distribution of β-catenin. In this study, we examined β-catenin expression in 47 primary colorectal tumors and the corresponding liver metastases. Immunohistochemical studies demonstrated loss of membranous β-catenin expression in 26% of primary tumors and 60% of liver metastases and a concomitant increase in cytoplasmic and nuclear staining. Widespread nuclear expression of β-catenin was found in 64% of primary tumors and 21% of liver metastases. No associations were found between any form of β-catenin expression and either tumor stage or tumor grade. Cellular distribution of β-catenin was also examined by detergent extraction and Western blot analysis in 16 primary tumors and 23 liver metastases. This analysis showed that most tumors demonstrated reduced β-catenin in the cytoskeletal fraction and increased β-catenin in the cytosolic fraction. Furthermore, 3 liver metastases were found to contain a truncated β-catenin protein of approximately M(r) 80,000. Immunoprecipitation studies showed that the truncated β-catenin proteins only bound weakly to E-cadherin and β-catenin compared with non-truncated β-catenin. These results demonstrate gross alterations in the cellular distribution of β-catenin in primary colorectal cancers with metastatic potential, as well as in the metastatic tumors. These changes may be the consequence of APC or β-catenin gene mutations, or possibly result from a post-translational modification of the E-cadherin-catenin complex.

Original languageEnglish
Pages (from-to)504-511
Number of pages8
JournalInternational Journal of Cancer
Volume82
Issue number4
DOIs
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Catenins
Colorectal Neoplasms
Cadherins
Neoplasm Metastasis
Neoplasms
Liver
Mutation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

β-Catenin expression in primary and metastatic colorectal carcinoma. / Hugh, Thomas J.; Dillon, Stephanie A.; O'Dowd, Gerry; Getty, Brian; Pignatelli, Massimo; Poston, Graeme J.; Kinsella, Anne R.

In: International Journal of Cancer, Vol. 82, No. 4, 1999, p. 504-511.

Research output: Contribution to journalArticle

Hugh, Thomas J. ; Dillon, Stephanie A. ; O'Dowd, Gerry ; Getty, Brian ; Pignatelli, Massimo ; Poston, Graeme J. ; Kinsella, Anne R. / β-Catenin expression in primary and metastatic colorectal carcinoma. In: International Journal of Cancer. 1999 ; Vol. 82, No. 4. pp. 504-511.
@article{3589bec121954b00818472b3f16e45bc,
title = "β-Catenin expression in primary and metastatic colorectal carcinoma",
abstract = "β-catenin plays a fundamental role in the regulation of the E-cadherin- catenin cell adhesion complex. It also functions in growth signalling events, independently of the cadherin-catenin complex, and these signalling pathways are disturbed in colorectal cancer. Mutations in either the APC or β- catenin genes in colorectal cancer cells result in up-regulation of protein expression and subsequent cytoplasmic and nuclear distribution of β-catenin. In this study, we examined β-catenin expression in 47 primary colorectal tumors and the corresponding liver metastases. Immunohistochemical studies demonstrated loss of membranous β-catenin expression in 26{\%} of primary tumors and 60{\%} of liver metastases and a concomitant increase in cytoplasmic and nuclear staining. Widespread nuclear expression of β-catenin was found in 64{\%} of primary tumors and 21{\%} of liver metastases. No associations were found between any form of β-catenin expression and either tumor stage or tumor grade. Cellular distribution of β-catenin was also examined by detergent extraction and Western blot analysis in 16 primary tumors and 23 liver metastases. This analysis showed that most tumors demonstrated reduced β-catenin in the cytoskeletal fraction and increased β-catenin in the cytosolic fraction. Furthermore, 3 liver metastases were found to contain a truncated β-catenin protein of approximately M(r) 80,000. Immunoprecipitation studies showed that the truncated β-catenin proteins only bound weakly to E-cadherin and β-catenin compared with non-truncated β-catenin. These results demonstrate gross alterations in the cellular distribution of β-catenin in primary colorectal cancers with metastatic potential, as well as in the metastatic tumors. These changes may be the consequence of APC or β-catenin gene mutations, or possibly result from a post-translational modification of the E-cadherin-catenin complex.",
author = "Hugh, {Thomas J.} and Dillon, {Stephanie A.} and Gerry O'Dowd and Brian Getty and Massimo Pignatelli and Poston, {Graeme J.} and Kinsella, {Anne R.}",
year = "1999",
doi = "10.1002/(SICI)1097-0215(19990812)82:4<504::AID-IJC6>3.0.CO;2-6",
language = "English",
volume = "82",
pages = "504--511",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - β-Catenin expression in primary and metastatic colorectal carcinoma

AU - Hugh, Thomas J.

AU - Dillon, Stephanie A.

AU - O'Dowd, Gerry

AU - Getty, Brian

AU - Pignatelli, Massimo

AU - Poston, Graeme J.

AU - Kinsella, Anne R.

PY - 1999

Y1 - 1999

N2 - β-catenin plays a fundamental role in the regulation of the E-cadherin- catenin cell adhesion complex. It also functions in growth signalling events, independently of the cadherin-catenin complex, and these signalling pathways are disturbed in colorectal cancer. Mutations in either the APC or β- catenin genes in colorectal cancer cells result in up-regulation of protein expression and subsequent cytoplasmic and nuclear distribution of β-catenin. In this study, we examined β-catenin expression in 47 primary colorectal tumors and the corresponding liver metastases. Immunohistochemical studies demonstrated loss of membranous β-catenin expression in 26% of primary tumors and 60% of liver metastases and a concomitant increase in cytoplasmic and nuclear staining. Widespread nuclear expression of β-catenin was found in 64% of primary tumors and 21% of liver metastases. No associations were found between any form of β-catenin expression and either tumor stage or tumor grade. Cellular distribution of β-catenin was also examined by detergent extraction and Western blot analysis in 16 primary tumors and 23 liver metastases. This analysis showed that most tumors demonstrated reduced β-catenin in the cytoskeletal fraction and increased β-catenin in the cytosolic fraction. Furthermore, 3 liver metastases were found to contain a truncated β-catenin protein of approximately M(r) 80,000. Immunoprecipitation studies showed that the truncated β-catenin proteins only bound weakly to E-cadherin and β-catenin compared with non-truncated β-catenin. These results demonstrate gross alterations in the cellular distribution of β-catenin in primary colorectal cancers with metastatic potential, as well as in the metastatic tumors. These changes may be the consequence of APC or β-catenin gene mutations, or possibly result from a post-translational modification of the E-cadherin-catenin complex.

AB - β-catenin plays a fundamental role in the regulation of the E-cadherin- catenin cell adhesion complex. It also functions in growth signalling events, independently of the cadherin-catenin complex, and these signalling pathways are disturbed in colorectal cancer. Mutations in either the APC or β- catenin genes in colorectal cancer cells result in up-regulation of protein expression and subsequent cytoplasmic and nuclear distribution of β-catenin. In this study, we examined β-catenin expression in 47 primary colorectal tumors and the corresponding liver metastases. Immunohistochemical studies demonstrated loss of membranous β-catenin expression in 26% of primary tumors and 60% of liver metastases and a concomitant increase in cytoplasmic and nuclear staining. Widespread nuclear expression of β-catenin was found in 64% of primary tumors and 21% of liver metastases. No associations were found between any form of β-catenin expression and either tumor stage or tumor grade. Cellular distribution of β-catenin was also examined by detergent extraction and Western blot analysis in 16 primary tumors and 23 liver metastases. This analysis showed that most tumors demonstrated reduced β-catenin in the cytoskeletal fraction and increased β-catenin in the cytosolic fraction. Furthermore, 3 liver metastases were found to contain a truncated β-catenin protein of approximately M(r) 80,000. Immunoprecipitation studies showed that the truncated β-catenin proteins only bound weakly to E-cadherin and β-catenin compared with non-truncated β-catenin. These results demonstrate gross alterations in the cellular distribution of β-catenin in primary colorectal cancers with metastatic potential, as well as in the metastatic tumors. These changes may be the consequence of APC or β-catenin gene mutations, or possibly result from a post-translational modification of the E-cadherin-catenin complex.

UR - http://www.scopus.com/inward/record.url?scp=0032837577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032837577&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19990812)82:4<504::AID-IJC6>3.0.CO;2-6

DO - 10.1002/(SICI)1097-0215(19990812)82:4<504::AID-IJC6>3.0.CO;2-6

M3 - Article

VL - 82

SP - 504

EP - 511

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -